Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to NHSScotland
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Amgen Ltd | 02354269 | ~£25,000,000 estimated from lot values | 1 lot Trastuzumab IV Infusion Vials | - |
| MSD | - | ~£25,000,000 estimated from lot values | 1 lot Trastuzumab IV Infusion Vials | - |
| Napp Pharmaceuticals | 03690299 | ~£33,500,000 estimated from lot values | 2 lots Rituximab IV Infusion Vials · Trastuzumab IV Infusion Vials | - |
| Pfizer Ltd | 00526209 | ~£33,500,000 estimated from lot values | 2 lots Rituximab IV Infusion Vials · Trastuzumab IV Infusion Vials | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£33,500,000 estimated from lot values | 2 lots Rituximab IV Infusion Vials · Trastuzumab IV Infusion Vials | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sandoz Ltd | 01547204 | ~£8,500,000 estimated from lot values | 1 lot Rituximab IV Infusion Vials | - |
This procurement was divided into 2 lots, each awarded separately. 9 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Rituximab IV Infusion Vials Jul 2020 – Jun 2022 | £8,500,000 £7,852,589 initial term | 4 | Pfizer Ltd Roche Products Ltd Napp Pharmaceuticals Sandoz Ltd | complete |
| Lot 2 Trastuzumab IV Infusion Vials Jul 2020 – Jun 2022 | £25,000,000 £3,301,190 initial term | 5 | Pfizer Ltd Roche Products Ltd Napp Pharmaceuticals Amgen Ltd MSD | complete |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £381,457,777 in 3,119 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 14 more public bodies (2010-08-03 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
Change to ITT response closing date
Published by the buyer on this notice. Check the original notice — details change and are not updated here.